Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Asparaginase erwinia chrysanthemi by Porton Biopharma for Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia): Likelihood of Approval
Asparaginase erwinia chrysanthemi is under clinical development by Porton Biopharma and currently in Phase III for Acute Lymphocytic Leukemia (ALL,...